Table of Content

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.1.1. Globalization of clinical trials
3.7.1.2. Adoption of new technology in clinical research
3.7.1.3. Growing disease variation and prevalence
3.7.1.4. Increasing research and development promoting outsourcing
3.7.2. Market Restraint Analysis
3.7.2.1. Regulations in new drug development
3.7.2.2. Pricing pressure
3.7.3. Industry Challenges
3.7.3.1. Rising cost of clinical trials
3.8. Clinical Trials: Market Analysis Tools
3.8.1. Industry Analysis - Porter’s
3.8.1.1. Supplier Power: (Moderate)
3.8.1.2. Buyer Power: (High)
3.8.1.3. Substitution Threat: (Low)
3.8.1.4. Threat from new entrant: (Low)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
3.8.5. Case Studies
Chapter 4. Clinical Trials Market: Segment Analysis, By phase, 2015 - 2026 (USD Million)
4.1. Definitions & Scope
4.2. Phase market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Clinical Trials Market, by Phase, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Phase I
4.5.2. Phase II
4.5.3. Phase III
4.5.4. Phase IV
Chapter 5. Clinical Trials Market: Segment Analysis, By Study Design, 2015 - 2026 (USD Million)
5.1. Definitions & Scope
5.2. Study design market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Clinical Trials Market, by study design, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Interventional
5.5.2. Observational
5.5.3. Expanded access
Chapter 6. Clinical Trials Market: Segment Analysis, By Indication, 2015 - 2026 (USD Million)
6.1. Definitions & Scope
6.2. Indication market share analysis, 2018 & 2026
6.3. Segment Dashboard
6.4. Global Clinical Trials Market, by indication, 2015 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
6.5.1. Autoimmune/inflammation
6.5.2. Pain management
6.5.3. Oncology
6.5.4. CNS condition
6.5.5. Diabetes
6.5.6. Obesity
6.5.7. Cardiovascular
Chapter 7. Clinical Trials Market: Regional Market Analysis, By Region, 2015 - 2026 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2018 & 2026
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2018
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2025:
7.8. North America
7.8.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
7.8.2. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.8.3. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.8.4. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.8.5. U.S.
7.8.5.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.8.5.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.8.5.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.8.6. Canada
7.8.6.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.8.6.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.8.6.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.9. Europe
7.9.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
7.9.2. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.9.3. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.9.4. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.9.5. Germany
7.9.5.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.9.5.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.9.5.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.9.6. U.K.
7.9.6.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.9.6.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.9.6.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.9.7. France
7.9.7.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.9.7.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.9.7.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.9.8. Italy
7.9.8.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.9.8.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.9.8.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.9.9. Spain
7.9.9.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.9.9.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.9.9.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.10. Asia Pacific
7.10.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
7.10.2. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.10.3. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.10.4. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.10.5. China
7.10.5.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.10.5.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.10.5.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.10.6. Japan
7.10.6.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.10.6.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.10.6.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.10.7. India
7.10.7.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.10.7.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.10.7.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.10.8. Thailand
7.10.8.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.10.8.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.10.8.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.10.9. South Korea
7.10.9.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.10.9.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.10.9.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.11. Latin America
7.11.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
7.11.2. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.11.3. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.11.4. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.11.5. Brazil
7.11.5.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.11.5.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.11.5.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.11.6. Mexico
7.11.6.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.11.6.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.11.6.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.11.7. Argentina
7.11.7.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.11.7.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.11.7.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.11.8. Colombia
7.11.8.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.11.8.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.11.8.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.12. Middle East and Africa
7.12.1. Market estimates and forecast, by country, 2015 - 2026 (USD Million)
7.12.2. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.12.3. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.12.4. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.12.5. South Africa
7.12.5.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.12.5.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.12.5.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.12.6. Saudi Arabia
7.12.6.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.12.6.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.12.6.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
7.12.7. UAE
7.12.7.1. Market estimates and forecast, by phase, 2015 - 2026 (USD Million)
7.12.7.2. Market estimates and forecast, by study design, 2015 - 2026 (USD Million)
7.12.7.3. Market estimates and forecast, by indication, 2015 - 2026 (USD Million)
Chapter 8. Clinical Trials Market - Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2018
8.4. Public Companies
8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4.2. Company Market Share/Ranking, by region
8.4.3. Competitive Dashboard Analysis
8.4.3.1. Market Differentiators
8.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
8.5. Private Companies
8.5.1. List of key emerging companies’ /technology disruptors/innovators
8.5.2. Funding Outlook (Optional)
8.5.3. Regional network map
8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.6. Supplier Ranking
8.7. Key companies profiled
8.7.1. IQVIA
8.7.1.1. Company Overview
8.7.1.2. Financial Performance
8.7.1.3. Product Benchmarking
8.7.1.4. Strategic Initiatives
8.7.2. PAREXEL International Corporation.
8.7.2.1. Company Overview
8.7.2.2. Financial Performance
8.7.2.3. Product Benchmarking
8.7.2.4. Strategic Initiatives
8.7.3. Pharmaceutical Product Development, LLC
8.7.3.1. Company Overview
8.7.3.2. Financial Performance
8.7.3.3. Product Benchmarking
8.7.3.4. Strategic Initiatives
8.7.4. Charles River Laboratory.
8.7.4.1. Company Overview
8.7.4.2. Financial Performance
8.7.4.3. Product Benchmarking
8.7.4.4. Strategic Initiatives
8.7.5. ICON Plc.
8.7.5.1. Company Overview
8.7.5.2. Financial Performance
8.7.5.3. Product Benchmarking
8.7.5.4. Strategic Initiatives
8.7.6. Wuxi AppTec Inc.
8.7.6.1. Company Overview
8.7.6.2. Financial Performance
8.7.6.3. Product Benchmarking
8.7.6.4. Strategic Initiatives
8.7.7. PRA Health Sciences.
8.7.7.1. Company Overview
8.7.7.2. Financial Performance
8.7.7.3. Product Benchmarking
8.7.7.4. Strategic Initiatives
8.7.8. SGS SA.
8.7.8.1. Company Overview
8.7.8.2. Financial Performance
8.7.8.3. Product Benchmarking
8.7.8.4. Strategic Initiatives
8.7.9. Syneos Health.
8.7.9.1. Company Overview
8.7.9.2. Financial Performance
8.7.9.3. Product Benchmarking
8.7.9.4. Strategic Initiatives
8.7.10. Chiltern International Ltd.
8.7.10.1. Company Overview
8.7.10.2. Financial Performance
8.7.10.3. Product Benchmarking
8.7.10.4. Strategic Initiatives
Chapter 9. KOL Commentary
Chapter 10. Recommendation



List of Figures



Figure 1 Market summary, 2016 (USD Million)
Figure 2 Market trends & outlook
Figure 3 Market segmentation & scope
Figure 4 Market driver relevance analysis (Current & future impact)
Figure 5 Pharmaceutical R&D spending, 2007 - 2012 (USD Billion)
Figure 6 Market restraint relevance analysis (Current & future impact)
Figure 7 Penetration & growth prospect mapping
Figure 8 SWOT Analysis, By Factor (political & legal, economic and social)
Figure 9 Porter’s Five Forces Analysis
Figure 10 Clinical trials market phase outlook key takeaways
Figure 11 Clinical trials market: Phase movement analysis
Figure 12 Global phase I market, 2015 - 2026 (USD Million)
Figure 13 Global phase II market, 2015 - 2026 (USD Million)
Figure 14 Global phase III market, 2015 - 2026 (USD Million)
Figure 15 Global phase IV market, 2015 - 2026 (USD Million)
Figure 16 Clinical trials market study design outlook key takeaways
Figure 17 Clinical trials market: Study design movement analysis
Figure 18 Global interventional market, 2015 - 2026 (USD Million)
Figure 19 Global observational market, 2015 - 2026 (USD Million)
Figure 20 Global expanded access trials market, 2015 - 2026 (USD Million)
Figure 21 Clinical trials market indication outlook key takeaways
Figure 22 Clinical trials market: Indication movement analysis
Figure 23 Global autoimmune based clinical trials market, 2015 - 2026 (USD Million)
Figure 24 Global rheumatoid arthritis based clinical trials market, 2015 - 2026 (USD Million)
Figure 25 Global multiple sclerosis based clinical trials market, 2015 - 2026 (USD Million)
Figure 26 Global osteoarthritis based clinical trials market, 2015 - 2026 (USD Million)
Figure 27 Global IBD based clinical trials market, 2015 - 2026 (USD Million)
Figure 28 Global other disease based autoimmune clinical trials market, 2015 - 2026 (USD Million)
Figure 29 Global pain management based clinical trials market, 2015 - 2026 (USD Million)
Figure 30 Global chronic pain based clinical trials market, 2015 - 2026 (USD Million)
Figure 31 Global acute pain based clinical trials market, 2015 - 2026 (USD Million)
Figure 32 Global oncology based clinical trials market, 2015 - 2026 (USD Million)
Figure 33 Global blood cancer based clinical trials market, 2015 - 2026 (USD Million)
Figure 34 Global solid tumors based clinical trials market, 2015 - 2026 (USD Million)
Figure 35 Global other cancer based clinical trials market, 2015 - 2026 (USD Million)
Figure 36 Global CNS conditions based clinical trials market, 2015 - 2026 (USD Million)
Figure 37 Global epilepsy based clinical trials market, 2015 - 2026 (USD Million)
Figure 38 Global PD based clinical trials market, 2015 - 2026 (USD Million)
Figure 39 Global HD based clinical trials market, 2015 - 2026 (USD Million)
Figure 40 Global stroke based clinical trials market, 2015 - 2026 (USD Million)
Figure 41 Global TBI based clinical trials market, 2015 - 2026 (USD Million)
Figure 42 Global ALS based clinical trials market, 2015 - 2026 (USD Million)
Figure 43 Global muscle regeneration based clinical trials market, 2015 - 2026 (USD Million)
Figure 44 Global other disease based CNS clinical trials market, 2015 - 2026 (USD Million)
Figure 45 Global diabetes based clinical trials market, 2015 - 2026 (USD Million)
Figure 46 Global Obesity based clinical trials market, 2015 - 2026 (USD Million)
Figure 47 Global cardiovascular based clinical trials market, 2015 - 2026 (USD Million)
Figure 48 Global other indication based clinical trials market, 2015 - 2026 (USD Million)
Figure 49 Regional market place: Key takeaways
Figure 50 Regional outlook, 2016 & 2025
Figure 51 North America clinical trials market, 2015 - 2026 (USD Million)
Figure 52 U.S. clinical trials market, 2015 - 2026 (USD Million)
Figure 53 Canada clinical trials market, 2015 - 2026 (USD Million)
Figure 54 Europe clinical trials market, 2015 - 2026 (USD Million)
Figure 55 U.K. clinical trials market, 2015 - 2026 (USD Million)
Figure 56 Germany clinical trials market, 2015 - 2026 (USD Million)
Figure 57 France clinical trials market, 2015 - 2026 (USD Million)
Figure 58 Italy clinical trials market, 2015 - 2026 (USD Million)
Figure 59 Spain clinical trials market, 2015 - 2026 (USD Million)
Figure 60 Asia Pacific clinical trials market, 2015 - 2026 (USD Million)
Figure 61 Japan clinical trials market, 2015 - 2026 (USD Million)
Figure 62 China clinical trials market, 2015 - 2026 (USD Million)
Figure 63 India clinical trials market, 2015 - 2026 (USD Million)
Figure 64 Thailand clinical trials market, 2015 - 2026 (USD Million)
Figure 65 South Korea clinical trials market, 2015 - 2026 (USD Million)
Figure 66 Latin America clinical trials market, 2015 - 2026 (USD Million)
Figure 67 Brazil clinical trials market, 2015 - 2026 (USD Million)
Figure 68 Mexico clinical trials market, 2015 - 2026 (USD Million)
Figure 69 Argentina clinical trials market, 2015 - 2026 (USD Million)
Figure 70 Colombia clinical trials market, 2015 - 2026 (USD Million)
Figure 71 MEA clinical trials market, 2015 - 2026 (USD Million)
Figure 72 South Africa clinical trials market, 2015 - 2026 (USD Million)
Figure 73 Saudi Arabia clinical trials market, 2015 - 2026 (USD Million)
Figure 74 UAE clinical trials market, 2015 - 2026 (USD Million)

 

List of Tables



Table 1 North America Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 2 North America Clinical Trials Market, by Study Design, 2014 - 2025 (USD Million)
Table 3 North America Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 4U.S. Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 5 U.S. Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 6U.S. Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 7Canada Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 8Canada Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 9Canada Clinical Trials Market, by Indication 2015 - 2026 (USD Million)
Table 10Europe Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 11 Europe Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 12 Europe Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 13 U.K. Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 14 U.K. Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 15 U.K Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 16 Germany Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 17 Germany Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 18 Germany Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 19 France Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 20 France Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 21 France Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 22 Italy Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 23 Italy Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 24 Italy Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 25 Spain Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 26 Spain Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 27 Spain Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 28 Asia Pacific Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 29 Asia Pacific Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 30 Asia Pacific Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 31 Japan Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 32 Japan Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 33 Japan Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 34 China Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 35 China Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 36 China Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 37 India Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 38 India Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 39 India Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 40 Thailand Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 41 Thailand Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 42 Thailand Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 43 South Korea Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 44 South Korea Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 45 South Korea Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 46 Latin America Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 47 Latin America Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 48 Latin America Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 49 Brazil Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 50 Brazil Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 51 Brazil Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 52 Mexico Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 53 Mexico Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 54 Mexico Clinical Trials Market, by Indication 2015 - 2026 (USD Million)
Table 55 Argentina Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 56 Argentina Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 57 Argentina Clinical Trials Market, by Indication 2015 - 2026 (USD Million)
Table 58 Colombia Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 59 Colombia Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 60 Colombia Clinical Trials Market, by Indication 2015 - 2026 (USD Million)
Table 61 MEA Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 62 MEA Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 63 MEA Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 64 South Africa Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 65 South Africa Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 66 South Africa Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 67 Saudi Arabia Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 68 Saudi Arabia Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 69 Saudi Arabia Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)
Table 70 UAE Clinical Trials Market, by Phase, 2015 - 2026 (USD Million)
Table 71 UAE Clinical Trials Market, by Study Design, 2015 - 2026 (USD Million)
Table 72 UAE Clinical Trials Market, by Indication, 2015 - 2026 (USD Million)